Cybersecurity & Cloud Systems

Cybersecurity Documentation for Premarket Approval (PMA) Submissions

February 9, 2024
|
By Dr. Ebot Eyong

Cybersecurity documentation is vital for PMA submissions to the FDA, ensuring device safety and effectiveness. This article outlines cybersecurity risk assessment, security controls, SBOM, vulnerability disclosure, incident response planning, labeling, monitoring, and documentation requirements.

Cybersecurity documentation is vital for PMA submissions to the FDA, ensuring device safety and effectiveness.

FDA Guidance on Cybersecurity Documentation

The FDA’s guidance document titled "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" (June 2025) provides recommendations for the industry on cybersecurity related to device design, labeling, and documentation for premarket submissions.

Key Components Outlined in FDA Guidance

  • Cybersecurity Risk Assessment: This involves identifying and assessing the cybersecurity risks associated with the medical device, including potential threats, vulnerabilities, and harm.
  • Security Controls: This involves implementing measures, including encryption, access controls, and incident response plans, to mitigate the identified risks.
  • Software Bill of Materials (SBOM): A comprehensive list detailing all software components utilized in the device, along with their versions and any known vulnerabilities.
  • Vulnerability Disclosure Policy: A defined process for reporting and addressing security vulnerabilities in the device.
  • Incident Response Plan: Procedures for responding to security incidents, including notification steps and mitigation strategies.

Premarket Submission Requirements

  • Cybersecurity Risk Management Report: This includes a detailed report that describes the cybersecurity risk assessment and the strategies for mitigating those risks.
  • Cybersecurity Documentation: Submission of comprehensive documentation detailing cybersecurity controls, which includes design specifications, testing protocols, and validation results.
  • Labeling and Instructions: Provide clear labels and instructions to inform users about cybersecurity risks and the strategies implemented for mitigation.

Key Components of Cybersecurity Documentation

  • System Security Plan: This document describes the purpose, scope, management, and security controls of the medical device system to safeguard the device and data.
  • Cybersecurity Incident Response Plan: It details procedures for handling incidents, including defining incident types and reporting requirements.
  • Change and Configuration Management Plan: This plan explains how to manage device configuration updates, including the processes for requesting, tracking, and documenting changes to maintain system integrity.
  • Continuous Monitoring Plan: Regular monitoring includes conducting vulnerability scans, assessments, and penetration tests to identify and reduce security risks.
  • Security Assessment Report: This report provides an overview of the system's strengths, weaknesses, and recommended fixes.
  • Action Plan and Milestones: This section outlines specific steps and deadlines for addressing security issues and implementing the recommended actions.

For more information, visit https://eemedicals.com/

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

AI & Digital Health

Why Health Apps Aren’t Enough Anymore

June 4, 2026
|
by Dr. Ebot Eyong

Your sleep data sits in one place. Your glucose trends live somewhere else. Your stress levels are isolated. Each app tells you what’s happening in its own narrow world—but your body doesn’t work that way. Health is interconnected. Poor sleep affects glucose. Stress impacts blood pressure. Mental health influences weight. When these signals are disconnected, you’re left guessing.

Read Article

AI & Digital Health

Case Study: Making Radiology AI Safe, Traceable, and Clinically Sustainable - A case for AI medical-device developers, imaging providers, and regulatory teams

August 20, 2026
|
Dr. Ebot Eyong

Radiology AI does not fail only at the algorithm level. It fails in the gaps between intended use, evidence, workflow, human oversight, change control, and real-world performance. This case study describes a representative, composite implementation designed to illustrate the E&E Regulatory Assurance operating model.

Read Article

CMC & FDA Submissions

Top 10 Premarket Authorization Challenges for Medical Device Manufacturers Navigating Regulatory Complexity from Concept to Market Approval

July 9, 2026
|
By Dr. Eyong Ebot

Discover the top 10 premarket authorization challenges facing medical device manufacturers and learn practical strategies to accelerate FDA 510(k), De Novo, and PMA approvals.

Read Article

AI & Digital Health

FDA Expands Digital Health Exemptions: Implications for AI-Enabled Medical Devices

December 18, 2025
|
By Dr. Ebot Eyong

FDA’s revised digital health guidance expands exemptions for certain low-risk digital health products from active regulatory oversight. This article explains how wearables, wellness products, clinical decision support tools, and AI-enabled software may be affected by the updated risk-based approach.

Read Article